However, in prostate cancer cells, PTEN reduces the function of BMI-1 to prevent tumorigenesis, which can be attributed to its interaction with BMI-1 in the nucleus [56], indicating that a PTEN/BMI-1 double-negative feedback loop may occur and govern EMT/CSC in certain types of cancer. This evidence concerns the gene PTEN and prostate carcinoma.